XML 24 R13.htm IDEA: XBRL DOCUMENT v3.8.0.1
1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
3 Months Ended
Mar. 31, 2018
Summary Of Significant Accounting Policies Tables  
Disaggregation of revenue
    Three-months Ended  
    March 31,    
    2018     2017  
CellerateRX Powder   $ 1,788,276     $ 1,442,938  
CellerateRX Gel     121,164       117,613  
HemaQuell     6,600       -  
Other revenue     45,747       44,695  
Total Revenue   $ 1,961,787     $ 1,605,246